A pilot clinical trial of recombinant human ACE2 in acute respiratory distress syndrome demonstrated that ACE2 decreased IL-6 concentrations, suggesting an anti-inflammatory effect of ACE226. The gene discussed is ACE2; the disease is acute respiratory distress syndrome.